Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1998-04-23
2000-02-29
Housel, James C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4241841, 4242341, 4242541, 424 931, 424 934, 4242401, 435243, 4352521, A61K 3900, A61K 3902, A61K 3910, A01N 6300, C12N 100
Patent
active
060306254
ABSTRACT:
An immunogenic composition, characterized in that it comprises an adenyl cyclase-hemolysin (Ac-Hly) protein, or an immunogenic portion of this AC-Hly, of a strain of Bordetella chosen from B. pertussis, B. parapertussis or B. bronchiseptica, and in that it comprises, in addition, a bacterial extract containing the expression products of the vrg genes of a strain of Bordetella chosen from B. pertussis, B. parapertussis or B. bronchiseptica, or a portion of these expression products which is sufficient to induce an immune response in a host to which the extract might be administered.
REFERENCES:
patent: 5095094 (1992-03-01), Brezin et al.
patent: 5595901 (1997-01-01), Rocancourt et al.
Bartoloni et al., "Engineering Bacterial Toxin for the Development of New Vaccine against Pertussis," Tokai J. Exp. Clin. Med., 13(Suppl):217-22 (1988).
Beattie et al., "Evidence that Modulation Requires Sequences Downstream of the Promoters of Two vir-Repressed Genes of Bordetella pertussis," J. Bacteriol., 172/12:6997-7004 (1990).
Beattie et al., "Repressor Binding to a Regulatory Site in the DNA Coding Sequence Is Sufficient To Confer Transcriptional Regulation of the vir-Repressed Genes (vrg Genes) in Bordetella pertussis," J. Bacteriol., 175/2:519-27 (1993)).
Beattie et al., "A vir-Repressed Gene of Bordetella pertussis is Required for Virulence," Infection and Immunity, 60/2:571-577 (1992).
Betsou et al., "CyaC-Mediated Activation is Important Not Only for Toxic but Also for Protective Activities of Bordetella pertussis Adenylate Cyclase-Hemolysin," Infection and Immunity, 61/9:3583-3589 (1993).
Brennan et al., "Identification of a 69-Kilodalton Nonfimbrial Protein as an Agglutinogen of Bordetella pertussis," Infection and Immunity, 56/12:3189-3195 (1988).
Charles et al., "Molecular cloning and characterization of protective outer membrane protein P.69 from Bordetella pertussis", Proc. Natl. Acad. Sci. USA, 86:3554-3558 (1989).
Friedman, "Bordetella pertussis Adenylate Cyclase: Isolation and Purification by Calmodulin-Sepharose 4B Chromatography", Infection and Immunity, 55/1:129-134 (1987).
Goldman et al., "Spontaneous phase variation in Bordetella pertussis is a multistep non-random process," EMBO Journal, 3/6:1353-1356 (1984).
Grimprel et al., "Long-Term Human Serum Antibody Responses after Immunization with Whole-Cell Pertussis Vaccine in France," Clinical & Diagostic Laboratory Immunology, 3/1:93-97 (1996).
Gross et al., "Targeted mutations that ablate either the adenylate cylase or hemolysin function of the bifunctional cyaA toxin of Bordetella pertussis abolish virulence," Proc. Natl. Acad. Sci. USA, 89:4898-4902 (1992).
Gueirard et al., Human Bordetella bronchiseptica Infection Related to Contact with Infected Animals: Persistence of Bacteria in Host, J. Clin. Microbiol., 33/8:2002-2006 (1995).
Gueirard et al., Human Bordetella bronchiseptica Infection Related to Contact with Infected Animals: Persistence of Bacteria in Host, J. Clin. Microbiol., 33/8:2002-2006 (1995).
Gueirard et al., "Virulence of Bordetella bronchiseptica: Role of Adenylate Cyclase-Hemolysin," Infection & Immunity, 61/10:4072-4078 (1993).
Gueirard et al., "Virulence of Bordetella bronchiseptica," Bacterial Protein Toxins, ed. Freer et al., Suppl. 24:152-153 (1994).
Glaser et al., "The calmodulin-sensitive adenylate cyclase of Bordetella pertussis: cloning and expression in Escherichia coli", Molecular Microbiology 2/1:19-30 (1988).
Guiso et al., Protective activity of Bordetella adenylate cyclase-hemolysin against bacterial colonization, Microbial Pathogenesis, 11:423-431 (1991).
Hackett et al., "Hemolytic, but Not Cell-invasive Activity, of Adenylate Cyclase Toxin is Selectively Affected by Differential Fatty-acylation in Escherichia coli", The Journal of Biological Chemistry, 270/35:20250-20253 (1995).
Hackett et al., Internal Lysine Palmitoylation in Adenylate Cyclase Toxin from Bordetella pertussis, Science, 226:433-435 (1994).
Hausman et al., Analysis of Proteins Encoded by the ptx and ptl Genes of Bordetella bronchiseptica and Bordetella parapertussis, Infection and Immunity, 64/10:4020-4026 (1996).
Hewlett et al., "Adenylate Cyclase Toxin from Bordetella pertussis: Identification and Purification of the Holotoxin Molecule", The Journal of Biological Chemistry, 264/32: 19379-19384 (1989).
Horiguchi et al., Effects of Bordetella bronchiseptica Dermonecrotic Toxin on the Structure and Function of Osteoblastic Clone MC3T3-E1 Cells, Infection and Immunity 59/3:1112-1116 (1991).
Iwaki et al., "Identification by in vitro complementation of regions required for cell-invasive activity of Bordetella pertussis adenylate cyclase toxin", Molecular Microbiology, 17/6:1015-1024 (1995).
Kessin et al., "Secreted Adenylate Cyclase of Bordetella pertussis: Calmodulin Requirements and Partial Purification of Two Forms," Journal of Bacteriology, 166/1:290-296 (1986).
Khelef et al., "Characterization of Murine Lung Inflammation after Infection with Parental Bordetella pertussis and Mutants Deficient in Adhesions or Toxins," Infectin and Immunity, 62/7:2893-2900 (1994).
Khelef et al., "Bordetella Species are Immunologically Different," Bacterial Protein Toxins ed. Freer et al., Suppl. 24:514-515 (1994).
Khelef et al., "Both adenylate cyclase and hemolytic activities are required by Bordetella pertussis to initiate infection," Microbial Pathogenesis, 12:227-235 (1992).
Knapp et al., "Two trans-Acting Regulatory Genes (vir and mod) Control Antigenic Modulation in Bordetella pertussis," J. Bacteriol. 170/11:5059-5066 (1988).
Ladant et al., "Bordetella pertussis Adenylate Cyclase: Purification, Characterization and Radioimmunoassay," The Journal of Biological Chemistry, 261/34:16264-162169 (1986).
Le Blay et al., "Antigenic polymorphism of the lipopolysaccharides from human and animal isolates of Bordetella bronchiseptica," Microbiology, 143:1433-1441 (1997).
Munoz et al., Mouse-Protecting and Histamine-Sensitizing Activities of Pertussigen and Fimbrial Hemagglutinin from Bordetella pertussis, Infection and Immunity,32/1:243-250 (1981).
Novotny et al., "Adenylate Cyclase Activity of a 68,000-Molecular-Weight Protein Isolated from the Outer Membrane of Bordetella bronchiseptica," Infection and Immunity, 50/1:199-206 (1985).
Novotny et al., "Biologic and Protective Properties of the 69-kDa Outer Membrane Protein of Bordetella pertussis: A Novel Formulation for an Acellular Pertussis Vaccine," Journal of Infectious Diseases, 164:114-22 (1991).
Novotny, "Bordetella Adenylate Cyclase: A Genus Specific Protective Antigen and Virulence Factor," Proceedings of the Fourth International Symposium on Pertussis, Developed Biol. Standard, 61:27-41 (1985).
Passerini de Rossi et al., "Flagellin, a major protein present in SDS-Page profiles of Sarkosyl-OMP-enriched fractions from Bordetella bronchiseptica Bvg--or modulated Bvg+ strains," Veterinary Microbiology, 56:65-77 (1997).
Pittman, "Pertussis Toxin: The Cause of the Harmful Effects and Prolonged Immunity of Whooping Cough. A Hypothesis," Reviews of Infectious Diseases, 1/3:401-412 (1979).
Shattuck et al., "Purification and Characterization of a Calmodulin-Sensitive Adenylate Cyclase from Bordetella pertussis," Biochemistry, 24:6356-6362 (1985).
Beattie et al. Journal of Bacteriology 172(12):6997-7004, 1990.
Beattie et al. Infection and Immunity 60(2):571-577, 1992.
Beattie et al. Journal of Bacteriology 175(2):519-527, 1993.
Knapp et al. Journal of Bacteriology 170(11):5059-5066, 1988.
Gueirard Pascale
Guiso Nicole
Housel James C.
Institut Pasteur
Ryan V.
LandOfFree
Bordetella pertussis and Bordetella parapertussis strains does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bordetella pertussis and Bordetella parapertussis strains, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bordetella pertussis and Bordetella parapertussis strains will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-680280